RE: The cost impact of unselective vs selective MammaPrint testing in early-stage breast cancer in Southern Africa

Breast. 2022 Apr:62:181. doi: 10.1016/j.breast.2022.01.009. Epub 2022 Jan 22.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Africa, Southern
  • Breast Neoplasms* / diagnosis
  • Breast Neoplasms* / drug therapy
  • Breast Neoplasms* / genetics
  • Chemotherapy, Adjuvant
  • Female
  • Humans